- VIEKIRA PAK associated drug-induced interstitial lung disease: Case series with systematic review of literature
-
Wong YJ, Chew SY, Hsiang JC, Thurairajah PH, Kumar R, Teo EK, Gokhale RS, Noor IB, Tan J
- KMID: 2451926
- Clin Mol Hepatol.
- 2019 Jun;25(2):218-222.
- doi: 10.3350/cmh.2018.0017
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
-
Wong YJ, Sharma S, Tosetti G, Qi X, Primignani M
- KMID: 2538222
- Clin Mol Hepatol.
- 2023 Jan;29(1):188-190.
- doi: 10.3350/cmh.2022.0408
-
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Features and Predictors of Dysplasia in Proximal Sessile Serrated Lesions
-
Tan YY, Tay GSK, Wong YJ, Li JW, Kwek ABE, Ang TL, Wang LM, Tan MTK
- KMID: 2518862
- Clin Endosc.
- 2021 Jul;54(4):578-588.
- doi: 10.5946/ce.2020.198
Background/Aims: Proximal colorectal cancers (CRCs) account for up to half of CRCs. Sessile serrated lesions (SSLs) are precursors to CRC. Proximal location and presence of dysplasia in SSLs predict higher... -
- CITED
-
- Close
- SHARE
-
- Close
- The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients
-
Wong YJ, Thurairajah PH, Kumar R, Fock KM, Law NM, Chong SY, Manejero FG, Ang TL, Teo EK, Tan J
- KMID: 2517631
- Clin Mol Hepatol.
- 2021 Jul;27(3):474-485.
- doi: 10.3350/cmh.2021.0015
Background/Aims: Despite the disproportionally high prevalence rates of hepatitis C virus (HCV) amongst the incarcerated population, eradication remains challenging due to logistic and financial barriers. Although treatment prioritization based on... -
- CITED
-
- Close
- SHARE
-
- Close
- Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients
-
Wong YJ, Zhaojin C, Tosetti G, Degasperi E, Sharma S, Agarwal S, Chuan L, Huak CY, Jia L, Xiaolong Q, Saraya A, Primignani M
- KMID: 2538210
- Clin Mol Hepatol.
- 2023 Jan;29(1):135-145.
- doi: 10.3350/cmh.2022.0181
Background/Aims: The utility of Baveno-VII criteria of clinically significant portal hypertension (CSPH) to predict decompensation in compensated advanced chronic liver disease (cACLD) patient needs validation. We aim to validate the... -
- CITED
-
- Close
- SHARE
-
- Close
